Jon D. Morrow, MD, MBA

Credentials

Positions

Clinical Associate Professor, Department of Obstetrics and Gynecology at NYU Grossman School of Medicine

Board Certifications

American Board of Obstetrics & Gynecology - Obstetrics & Gynecology, 1995

Education and Training

MBA from Columbia University, 2002
Residency, Northwestern University - Prentice Women's Hospital, Obstetrics & Gynecology, 1993
MD from McGill University, 1989

Is this your profile?

Edit profile

Insurance Plans Accepted

Jon D. Morrow, MD, MBA does not accept insurance.

Locations and Appointments

Tisch Hospital, Labor & Delivery

550 First Avenue, 8th Floor, New York, NY 10016

View Map

Phone

212-263-5640

Research My Research

Interests

informatics, EMR usability, overactive bladder, OAB, healthcare IT , clinical workflows, EHR usability, user-interface design, quality improvement, medical quality, labor & delivery, synthetic data

Academic office

550 First Avenue

TH8

New York, NY 10016

Phone

212-263-5640

These focus areas and their associated publications are derived from PubMed and the MeSH term library. *

represents one publication

Loading...

*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

Publications

Demonstrating an approach for evaluating synthetic geospatial and temporal epidemiologic data utility: Results from analyzing >1.8 million SARS-CoV-2 tests in the United States National COVID Cohort Collaborative (N3C)

Thomas, Jason A; Foraker, Randi E; Zamstein, Noa; Morrow, Jon D; Payne, Philip R O; Wilcox, Adam B

Journal of the American Medical Informatics Association. 2022 Jul 12; 29(8):1350-1365
Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials

DuBeau, Catherine E; Morrow, Jon D; Kraus, Stephen R; Creanga, Dana; Bavendam, Tamara

Neurourology & urodynamics. 2012 Nov ; 31(8):1258-65
The effect of elective sham dose escalation on the placebo response during an antimuscarinic trial for overactive bladder symptoms

Staskin, David R; Michel, Martin C; Sun, Franklin; Guan, Zhonghong; Morrow, Jon D

Journal of urology. 2012 May ; 187(5):1721-6

Read All Publications (13)

Conditions We Treat

Our Story

Jon D. Morrow, MD, MBA

Credentials

Positions

Board Certifications

Education and Training

Insurance Plans Accepted

Locations and Appointments

Tisch Hospital, Labor & Delivery

Phone

Research My Research

Interests

Academic Contact

Academic office

Phone

Research Interests Timeline

Publications

Demonstrating an approach for evaluating synthetic geospatial and temporal epidemiologic data utility: Results from analyzing >1.8 million SARS-CoV-2 tests in the United States National COVID Cohort Collaborative (N3C)

Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials

The effect of elective sham dose escalation on the placebo response during an antimuscarinic trial for overactive bladder symptoms